The Emergence of GPR119 Agonists as Anti-Diabetic Agents

被引：48

作者：

Jones, Robert M. ^{[1
]}

Leonard, James N. ^{[1
]}

机构：

[1] Arena Pharmaceut, San Diego, CA 92121 USA

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 44 | 2009年 / 44卷

关键词：

PROTEIN-COUPLED RECEPTOR; GLUCAGON-LIKE PEPTIDE-1; GASTROINTESTINAL-TRACT; INSULIN-SECRETION; GLYCEMIC CONTROL; G-PROTEIN-COUPLED-RECEPTOR-119; OLEOYLETHANOLAMIDE; DISCOVERY; DOPAMINE; RELEASE;

D O I：

10.1016/S0065-7743(09)04407-8

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：149 / 170

页数：22

共 70 条

[1]

Alper P., 2008, WO Pat. Appl., Patent No. 2008097428

[2]

AMMALA C, 2008, KEYST S ISL BET CELL

[3]

Ammala C., 2008, Patent No. [2008008895, WO 2008/008895A1]

[4]

[Anonymous], 2007, Patent, Patent No. [WO 2007116229, 2007116229]

[5]

[Anonymous], 2008, Patent, Patent No. [2008109702, WO 2008109702]

[6]

[Anonymous], 2009, Patent, Patent No. [WO 2009014910, 2009014910]

[7]

[Anonymous], 2008, Patent, Patent No. [2008025799, WO 2008025799]

[8]

*AR PHARM, 2004, AR PHARM ANN SEL 2 A

[9]

*AR PHARM, 2008, AR PHARM ANN APD668

[10]

*AR PHARM, 2006, AR PHARM ANN ORTH EX

← 1 2 3 4 5 6 7 →